Document is current
Any future updates will be listed below
-
Authors
García-Sempere, Aníbal
Hurtado Navarro, Isabel
Robles-Cabaniñas, Celia
Carrillo-Arenas, María Fernanda
Lluch Oltra, Anna
Tabarés-Seisdedos, Rafael
Baeza, Inmaculada
Llopis-Cardona, Fran
Gamón, Verónica
Rodríguez-Bernal, Clara
Peiró, Salvador
Sanfélix-Gimeno, Gabriel
-
Funding
Funding for this research was provided by:
Fundación Española para la Ciencia y la Tecnología (FCT-24-20488, FCT-24-20488, FCT-24-20488, FCT-24-20488, FCT-24-20488, FCT-24-20488, FCT-24-20488, FCT-24-20488, FCT-24-20488, FCT-24-20488)
Instituto de Salud Carlos III (RD21/0016/0006 and RD24/0005/0009, RD21/0016/0006 and RD24/0005/0009, RD21/0016/0006 and RD24/0005/0009, RD21/0016/0006 and RD24/0005/0009, PID2021-129099OB-I00, RD21/0016/0006 and RD24/0005/0009, RD21/0016/0006 and RD24/0005/0009, RD21/0016/0006 and RD24/0005/0009, RD21/0016/0006 and RD24/0005/0009)
Consejería de Educación, Valencia (CIPROM/2022/58)
FUNDACIO CLINIC RECERCA BARCELONA (FCRB_IPB 2-2023)
- License Information
-
More Information
Article History
Received: 29 May 2025
Accepted: 27 September 2025
First Online: 15 October 2025
Declarations
:
: The study was reviewed and approved by the Ethics Committee for Drug Research of the “Hospital Clínico-Universitario de Valencia” (Order 2025/042, Resolution 434, March 3, 2025). Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.
: IB has received honoraria or funding to attend conferences from Angelini and Lundbeck. The rest of authors declare that the research was conducted in the absence of any additional commercial or financial relationships that could be construed as a potential conflict of interest.
